The politics of emergency contraception

New England Journal of Medicine

Volumn 366, Issue 2, 2012, Pages 101-102

  Wood, Alastair J J ^a   Drazen, Jeffrey M ^b   Greene, Michael F ^b  

^a Symphony Capital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; NON PRESCRIPTION DRUG;

ADOLESCENT PREGNANCY; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CONTRACEPTION; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES; WOMEN'S HEALTH; ADOLESCENT; ARTICLE; FEMALE; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; POLITICS;

ADOLESCENT; CONTRACEPTION, POSTCOITAL; DRUG APPROVAL; FEMALE; GOVERNMENT REGULATION; HEALTH POLICY; HUMANS; POLITICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84855995447     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1114439     Document Type: Article

References (5)

1. Sebelius K. Memorandum to Margaret A. Hamburg, M.D. December 7, 2011 (http://www.hhs.gov/news/press/2011pres/12/20111207a.pdf).
2. Food and Drug Administration. Statement from FDA Commissioner Margaret Hamburg, M.D., on Plan B One-Step. December 7, 2011 (http://www.fda.gov/ NewsEvents/Newsroom/ucm282805.htm).
3. Wood AJJ, Drazen JM, Greene MF. A sad day for science at the FDA. N Engl J Med 2005;353:1197-9. (Pubitemid 41345939)
4. Department of Health and Human Services. A statement by U.S. Department of Health and Human Services Secretary Kathleen Sebelius. December 7, 2011 (http://www.hhs.gov/news/press/2011pres/12/20111207a.html).
5. von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:1803-10. (Pubitemid 35449417)